Back

SGLT 2 inhibitor suppresses atrial fibrillation in the canine model of atrial fibrillation.

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Atrial fibrillation - General 2 Disease Modelling ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Ryo Nishinarita

Nerima-Hikarigaoka Hospital, Tokyo (Japan)

6 More presentations in this session

Presentation thumbnail
Four targeted therapies and less than four targeted therapies of underlying conditions against conventional therapy in atrial fibrillation - data from the RACE 3 study
Miss B. Nguyen (Groningen, NL)
Abstract Slides
Presentation thumbnail
Association of left atrial size with ischemic and bleeding risk scores in patients with non-valvular atrial fibrillation
Doctor L. Enriquez Rodriguez (Soria, ES)
Abstract Slides
Presentation thumbnail
How could non-vitamin k antagonist oral anticoagulants change clinical practice for stroke prevention and improve outcomes in patients with newly-diagnosed atrial fibrillation?
Doctor T. Chao (Taipei, TW)
Abstract
Presentation thumbnail
High body mass index and outcomes of dual antithrombotic therapy with dabigatran and a P2Y12 inhibitor in patients with atrial fibrillation undergoing PCI: Results from RE-DUAL PCI
Doctor R. De Caterina (Pisa, IT)
Abstract Slides
Presentation thumbnail
Atrial fibrillation and risk of pulmonary arterial hypertension. Swedisk nationwide registry study
Assistant Professor B. Hornestam (Gothenburg, SE)
Abstract Slides

Access the full session

Session thumbnail
Atrial fibrillation - General 2

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018
You may be interested in
thumbnail
Congress Presentation
In-silico insights into personalised therapy selection of anti-arrhythmic drugs and ablation using patient-specific biatrial models for atrial fibrillation
thumbnail
Congress Presentation
Atrial-tissue (genetic, molecular, and histological) signs of atrial cardiomyopathy
thumbnail
Congress Session
Basic science and arrhythmia pathophysiology

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources